CNTO 888

· Centocor, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CNTO 888, covering 2010-10-22 to 2015-12-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]

See pricing